Metsera to Present at Bank of America 2025 Global Healthcare Conference
Metsera (Nasdaq: MTSR), a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and metabolic diseases, has announced its participation in the Bank of America 2025 Global Healthcare Conference. CEO Whit Bernard will deliver a presentation on Wednesday, May 14, 2025, from 2:20 to 2:35 P.M. PDT (5:20 – 5:35 P.M. EDT). Interested parties can access a live webcast of the presentation through the Events page in the Investors & News section of Metsera's website at investors.metsera.com.
Metsera (Nasdaq: MTSR), un'azienda biofarmaceutica in fase clinica specializzata nello sviluppo di medicinali di nuova generazione per l'obesità e le malattie metaboliche, ha annunciato la sua partecipazione alla Bank of America 2025 Global Healthcare Conference. Il CEO Whit Bernard terrà una presentazione il mercoledì 14 maggio 2025, dalle 14:20 alle 14:35 PDT (17:20 – 17:35 EDT). Gli interessati potranno seguire la diretta streaming della presentazione attraverso la pagina Eventi nella sezione Investitori & Notizie del sito web di Metsera all'indirizzo investors.metsera.com.
Metsera (Nasdaq: MTSR), una empresa biofarmacéutica en fase clínica enfocada en desarrollar medicamentos de próxima generación para la obesidad y enfermedades metabólicas, ha anunciado su participación en la Bank of America 2025 Global Healthcare Conference. El CEO Whit Bernard realizará una presentación el miércoles 14 de mayo de 2025, de 2:20 a 2:35 P.M. PDT (5:20 – 5:35 P.M. EDT). Las personas interesadas podrán acceder a la transmisión en vivo de la presentación a través de la página de Eventos en la sección de Inversores y Noticias del sitio web de Metsera en investors.metsera.com.
Metsera (나스닥: MTSR)는 비만 및 대사 질환을 위한 차세대 의약품 개발에 주력하는 임상 단계의 바이오제약 회사로, Bank of America 2025 Global Healthcare Conference에 참가한다고 발표했습니다. CEO Whit Bernard는 2025년 5월 14일 수요일 오후 2시 20분부터 2시 35분까지 PDT(동부시간 오후 5시 20분~5시 35분)에 발표를 진행할 예정입니다. 관심 있는 분들은 Metsera 웹사이트의 투자자 및 뉴스 섹션 내 이벤트 페이지인 investors.metsera.com에서 발표 실시간 웹캐스트를 시청할 수 있습니다.
Metsera (Nasdaq : MTSR), une société biopharmaceutique en phase clinique spécialisée dans le développement de médicaments de nouvelle génération pour l'obésité et les maladies métaboliques, a annoncé sa participation à la Bank of America 2025 Global Healthcare Conference. Le PDG Whit Bernard présentera le mercredi 14 mai 2025, de 14h20 à 14h35 PDT (17h20 – 17h35 EDT). Les personnes intéressées pourront accéder à la diffusion en direct de la présentation via la page Événements dans la section Investisseurs & Actualités du site web de Metsera à l'adresse investors.metsera.com.
Metsera (Nasdaq: MTSR), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung von Medikamenten der nächsten Generation für Adipositas und Stoffwechselerkrankungen spezialisiert hat, hat seine Teilnahme an der Bank of America 2025 Global Healthcare Conference angekündigt. CEO Whit Bernard wird am Mittwoch, den 14. Mai 2025, von 14:20 bis 14:35 Uhr PDT (17:20 – 17:35 Uhr EDT) eine Präsentation halten. Interessierte können die Live-Übertragung der Präsentation über die Veranstaltungsseite im Bereich Investoren & Nachrichten auf der Website von Metsera unter investors.metsera.com verfolgen.
- None.
- None.
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit Bernard, its Chief Executive Officer, will present at the Bank of America 2025 Global Healthcare Conference on Wednesday, May 14 at 2:20 - 2:35 P.M. PDT (5:20 – 5:35 P.M. EDT).
A live webcast of the presentation will be available on the Events page in the Investors & News section of the Metsera website at investors.metsera.com.
About Metsera
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Metsera was founded in 2022 and is based in New York City. For more information, please visit us at www.metsera.com and follow us on LinkedIn and X.
Metsera may use its website as a distribution channel of material information about the Company. Financial and other important information regarding the Company is routinely posted on and accessible through the Investors & News section of its website at investors.metsera.com. In addition, you may sign up to automatically receive email alerts and other information about the Company by using the “Email Alerts” option on the Investors & Media page and submitting your email address.
Forward-Looking Statements
This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Metsera disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act's Safe Harbor for forward-looking statements. Examples of such statements include, but are not limited to, statements relating to Metsera's expectations regarding participation in the Bank of America 2025 Global Healthcare Conference, its research and development activities, and its product candidates. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to the risks related to Metsera’s business outlined in Metsera’s filings with the Securities and Exchange Commission, including in the “Risk Factors” section of its Annual Report on Form 10-K for the year ended December 31, 2024. Forward-looking statements are not guarantees of future performance, and Metsera’s actual results of operations, financial condition and liquidity, and the development of the industry in which it operates, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that Metsera makes in this press release speak only as of the date of this press release. Metsera assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.
Contact:
Jono Emmett
Metsera
media@metsera.com
FAQ
When is Metsera (MTSR) presenting at the Bank of America Healthcare Conference 2025?
Who will represent Metsera (MTSR) at the Bank of America Healthcare Conference 2025?
How can I watch Metsera's (MTSR) presentation at the Bank of America Healthcare Conference?
What is Metsera's (MTSR) main business focus?
